Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020

JAMA Netw Open. 2021 Apr 1;4(4):e218530. doi: 10.1001/jamanetworkopen.2021.8530.


This cross-sectional study uses data from the US Food and Drug Administration (FDA) to review the postmarketing requirements and commitments attached to new vaccines approved for use in the past 15 years in the United States.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cross-Sectional Studies
  • Drug Approval*
  • Drug Industry / legislation & jurisprudence
  • Drug Monitoring
  • Humans
  • Product Surveillance, Postmarketing*
  • Research* / legislation & jurisprudence
  • Social Control, Formal*
  • United States
  • United States Food and Drug Administration*
  • Vaccines*


  • Vaccines